Journal Article
Meta-Analysis
Review
Systematic Review
Add like
Add dislike
Add to saved papers

[Meta-analysis of randomized controlled trials comparing selective laser trabeculoplasty with prostaglandin analogue in the primary treatment of open-angle glaucoma or ocular hypertention].

OBJECTIVE: To compare the efficacy of selective laser trabeculoplasty (SLT) versus prostaglandinanalogue (PGA) in the treatment of open angle glaucoma (OAG) and ocular hypertension (OHT).

METHODS: Literature analysis.Systematic review of randomized controlled trials comparing SLT versus PGA, identified by searching literatures including Medline (January, 1966-December, 2012), EMBASE Reviews (January, 1974-December, 2012) OVID Evidence-Based Medicine Reviews (January, 1966-December, 2012), Chinese BioMedical Literature Database SinoMed (January, 1966-December, 2012), and CNKI (January, 1999-December, 2012). RevMan 5.0 was used to do meta-analysis.

RESULTS: Three publications reporting 3 trials, 161 participants (231 eyes) with OHT or OAG were included for meta-analysis.IOP reduction favored PGA group, weighted mean difference (WMD) = -0.85[1 mmHg = 0.133 kPa; 95% confidence interval (CI) (-1.43 to -0.27), no significant heterogeneity present (P = 0.82, I² = 0%)].Success rates are equal in two groups [OR = 0.70, 95%CI = (0.49 to 1.19) , no significant heterogeneity present (P = 0.58, I² = 0%)]. Eyes underwent additional antiglaumatous interventions favored SLT group, OR = 1.11 [95%CI = (0.60 to 2.06), significant heterogeneity present, (P = 0.08, I² = 61%)].

CONCLUSIONS: As primary therapy of OAG or OHT, SLT is no more effective than PGA in success rate. IOP reduction affected by SLT is not effective than PGA. Compared with PGA, SLT can reduce the use of anti-glaucoma medications.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app